Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work .
Who can participate
Age range40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being classified as GOLD stage 3 or 4 based on spirometric evaluation in the medical history.
* Having a hospital admission within the specified time frame, evaluated by a pulmonary specialist, and admitted to the pulmonary diseases service with a diagnosis of COPD exacerbation.
* Being 40 years of age or older.
* Voluntarily agreeing to participate in the study.
Exclusion Criteria:
* Having a hospital admission with a diagnosis of asthma attack in the last 5 years.
* Monitoring suspicious focal points for pneumonia on lung radiology.
* Hospitalization due to reasons other than exacerbation despite having a diagnosis of COPD.
* Presence of pulmonary fibrosis or suspicious findings of fibrosis on radiology.
* Systemic fungal infections.
* Having cognitive impairment affecting the decision to participate in the study, such as confusion, orientation disorder, or dementia.
* Patients with lung cancer or metastasis in the lungs.
* Diagnosis of conditions provoking shortness of breath other than COPD exacerbation, such as pneumonia, pneumothorax, heart failure, and pulmonary embolism.
* Presence of a new-onset rhythm disorder or ischemic changes requiring intervention on the EKG, excluding sinus tachycardia and multifocal atrial tachycardia.
* Chronic kidney failure requiring hemodialysis.
* Patients with conditions causing weakness in the lower extremities, such as arthritis, neurological disease, deep vein thrombosis, peripheral artery disease, muscle wea…
What they're measuring
1
COPD assessment test
Timeframe: The first and last day of the training will be measured an avarage 7 days
2
Clinical COPD Questionnaire
Timeframe: The first and last day of the training will be measured an avarage 7 days
3
mMRC dyspnea scale
Timeframe: The first and last day of the training will be measured an avarage 7 days
4
Richard-Campbell Sleep Questionnaire
Timeframe: The first and last day of the training will be measured an avarage 7 days
5
30 second sit and stand
Timeframe: The first and last day of the training will be measured an avarage 7 days
6
BODE index
Timeframe: The first and last day of the training will be measured an avarage 7 days
7
chest circumference measurements
Timeframe: The first and last day of the training will be measured an avarage 7 days